Postoperative residual vertical deviation affects quality of life in Asian patients with thyroid-associated ophthalmopathy (Graves ophthalmopathy).
Decompression surgery
Diplopia
Graves ophthalmopathy
Graves’ Ophthalmopathy Quality-of-life questionnaire
Strabismus surgery
Vertical deviation
Journal
Japanese journal of ophthalmology
ISSN: 1613-2246
Titre abrégé: Jpn J Ophthalmol
Pays: Japan
ID NLM: 0044652
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
18
09
2022
accepted:
09
03
2023
medline:
22
5
2023
pubmed:
20
4
2023
entrez:
20
04
2023
Statut:
ppublish
Résumé
To evaluate the treatment effect of strabismus surgery for Graves ophthalmopathy in an ethnic Chinese population. A prospective clinical study. Thirty-one patients with Graves ophthalmopathy who had undergone strabismus surgery at National Taiwan University Hospital between 2012 and 2013 were consecutively recruited. The subjective outcome was evaluated using the Graves' Ophthalmopathy Quality-of-Life (GO-QoL) questionnaire, and the ocular deviation was measured preoperatively and postoperatively by use of a prism cover test. The GO-QoL scores for visual functioning and appearance improved significantly after surgery (preoperative scores 32.6 ± 19.9 and 43.8 ± 26.4, postoperative scores 55.2 ± 24.4 and 54.1 ± 27.6, respectively; P < .05). Motor success was achieved in 61.3% of the patients, and their postoperative visual scores were higher (61.5 ± 22.5) than the scores of those who experienced motor failure (45.3 ± 26.8, P = .048). The postoperative visual function scores showed a negative correlation with the residual vertical deviation (R GO-QoL scores and ocular deviation improved significantly after strabismus surgery. Precise correction of vertical deviation was of greater importance than horizontal deviation for visual function scores. Our surgical methods were effective for the correction of vertical deviation in Graves ophthalmopathy.
Identifiants
pubmed: 37079164
doi: 10.1007/s10384-023-00990-z
pii: 10.1007/s10384-023-00990-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
326-334Informations de copyright
© 2023. Japanese Ophthalmological Society.
Références
Terwee CB, Gerding MN, Dekker FW, Prummel MF, Wiersinga WM. Development of a disease specific quality of life questionnaire for patients with Graves’ ophthalmopathy: the GO-QOL. Br J Ophthalmol. 1998;82:773–9.
doi: 10.1136/bjo.82.7.773
pubmed: 9924370
pmcid: 1722683
Terwee CB, Gerding MN, Dekker FW, Prummel MF, van der Pol JP, Wiersinga WM. Test-retest reliability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves’ ophthalmopathy. J Clin Epidemiol. 1999;52:875–84.
doi: 10.1016/S0895-4356(99)00069-4
pubmed: 10529028
Terwee CB, Dekker FW, Mourits MP, Gerding MN, Baldeschi L, Kalmann R, et al. Interpretation and validity of changes in scores on the Graves’ ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. Clin Endocrinol (Oxf). 2001;54:391–8.
doi: 10.1046/j.1365-2265.2001.01241.x
pubmed: 11298093
Terwee CB, Wakelkamp I, Tan S, Dekker F, Prummel MF, Wiersinga W. Long-term effects of Graves’ ophthalmopathy on health-related quality of life. Eur J Endocrinol. 2002;146:751–7.
doi: 10.1530/eje.0.1460751
pubmed: 12039694
Nasr E, Khater S, Nehme-Nasr D, Azoury F, Jambart S. Corticosteroids and radiotherapy in the treatment of Graves’ ophthalmopathy. J Med Liban. 2010;58:86–90.
pubmed: 20549894
Cheng AM, Wei YH, Tighe S, Sheha H, Liao SL. Long-term outcomes of orbital fat decompression in Graves’ orbitopathy. Br J Ophthalmol. 2018;102:69–73.
doi: 10.1136/bjophthalmol-2016-309888
pubmed: 28450378
European Group on Graves’ Orbitopathy (EUGOGO), Mourits MP, Bijl H, Altea MA, Baldeschi L, Boboridis K, Currò N, et al. Outcome of orbital decompression for disfiguring proptosis in patients with Graves’ orbitopathy using various surgical procedures. Br J Ophthalmol. 2009;93:1518–23.
doi: 10.1136/bjo.2008.149302
Prummel MF, Terwee CB, Gerding MN, Baldeschi L, Mourits MP, Blank L, et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves’ ophthalmopathy. J Clin Endocrinol Metab. 2004;89:15–20.
doi: 10.1210/jc.2003-030809
pubmed: 14715820
Lin IC, Lee CC, Liao SL. Assessing quality of life in taiwanese patients with Graves’ ophthalmopathy. J Formos Med Assoc. 2015;114:1047–54.
doi: 10.1016/j.jfma.2013.12.002
pubmed: 24434244
Farid M, Roch-Levecq AC, Levi L, Brody BL, Granet DB, Kikkawa DO. Psychological disturbance in Graves’ ophthalmopathy. Arch Ophthalmol. 2005;123:491–6.
doi: 10.1001/archopht.123.4.491
pubmed: 15824222
Yeatts RP. Quality of life in patients with Graves’ ophthalmopathy. Trans Am Ophthalmol Soc. 2005;103:368–411.
pubmed: 17057811
pmcid: 1447582
Coulter I, Frewin S, Krassas GE, Perros P. Psychological implications of Graves’ Orbitopathy. Eur J Endocrinol. 2007;157:127–31.
doi: 10.1530/EJE-07-0205
pubmed: 17656589
Garrity JA, Fatourechi V, Bergstralh EJ, Bartley GB, Beatty CW, DeSanto LW, et al. Results of transantral orbital decompression in 428 patients with severe Graves’ ophthalmopathy. Am J Ophthalmol. 1993;15:116:533–47.
doi: 10.1016/S0002-9394(14)73194-0
Goldberg RA, Perry JD, Hortaleza V, Tong JT. Strabismus after balanced medial plus lateral wall versus lateral wall only orbital decompression for dysthyroid orbitopathy. Ophthalmic Plast Reconstr Surg. 2000;16:271–7.
doi: 10.1097/00002341-200007000-00004
pubmed: 10923974
Ben Simon GJ, Syed HM, Lee S, Wang DY, Schwarcz RM, McCann JD, et al. Strabismus after deep lateral wall orbital decompression in thyroid-related orbitopathy patients using automated Hess screen. Ophthalmology. 2006;113:1050–5.
doi: 10.1016/j.ophtha.2006.02.015
pubmed: 16751042
Sasim IV, Berendschot TT, van Isterdael C, Mourits MP. Planning health care for patients with Graves’ orbitopathy. Graefes Arch Clin Exp Ophthalmol. 2008;246:1315–21.
doi: 10.1007/s00417-008-0842-3
pubmed: 18581132
pmcid: 2491431
Jellema HM, Saeed P, Mombaerts I, Dolman PJ, Garrity J, Kazim M, et al. Objective and subjective outcomes of strabismus surgery in Graves’ orbitopathy: a prospective multicentre study. Acta Ophthalmol. 2017;95:386–91.
doi: 10.1111/aos.13367
pubmed: 28133945
Jellema HM, Merckel-Timmer E, Kloos R, Saeed P, Mourits MP. Quality of life improves after strabismus surgery in patients with Graves’ orbitopathy. Eur J Endocrinol. 2014;170:785–9.
doi: 10.1530/EJE-13-0973
pubmed: 24493116
Liao SL, Wei YH, Chuang AYC. The role of rectus muscle myectomy in the management of large-angle strabismus for Graves’ ophthalmopathy. Eye (Lond). 2017;31:1027–33.
doi: 10.1038/eye.2017.28
pubmed: 28257132
Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin Endocrinol. 1997;47:9–14.
doi: 10.1046/j.1365-2265.1997.2331047.x
Honglertnapakul W, Cavuoto KM, McKeown CA, Capó H. Surgical treatment of strabismus in thyroid eye disease: characteristics, dose-response, and outcomes. J AAPOS. 2020;24:72e1–7.
doi: 10.1016/j.jaapos.2019.12.014
Bradley EA, Sloan JA, Novotny PJ, Garrity JA, Woog JJ, West SK. Evaluation of the National Eye Institute visual function questionnaire in Graves’ ophthalmopathy. Ophthalmology. 2006;113:1450–4.
doi: 10.1016/j.ophtha.2006.02.060
pubmed: 16769116
Bharadwaj SR, Hoenig MP, Sivaramakrishnan VC, Karthikeyan B, Simonian D, Mau K, et al. Variation of binocular-vertical fusion amplitude with convergence. Invest Ophthalmol Vis Sci. 2007;48:1592–600.
doi: 10.1167/iovs.06-1018
pubmed: 17389488
Lee JKS, Hsieh C, Wei YH, Liao SL. The impact of orbital bony or fat decompression on the outcome of strabismus surgery in patients with Graves’ ophthalmopathy. J Formos Med Assoc. 2019;118:387–94.
doi: 10.1016/j.jfma.2018.06.009
pubmed: 30646996
Kim MH, Park KA, Oh SY. The effect of previous orbital decompression on results of strabismus surgery in patients with Graves’ ophthalmopathy. J AAPOS. 2013;17:188–91.
doi: 10.1016/j.jaapos.2012.10.019
pubmed: 23528374
Akbari MR, Mirmohammadsadeghi A, Mahmoudzadeh R, Veisi A. Management of thyroid eye disease-related strabismus. J Curr Ophthalmol. 2020;23:32:1–13.